Figure S4 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts

作者：Bomiao Hu, Marc Wiesehöfer, Fernando J. de Miguel, Zongzhi Liu, Lok-Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal Estape, Zenta Walther, Dejian Zhao, Francesc López‐Giráldez, Anna Wurtz, Guoping Cai, Rong Fan, Scott Gettinger, Andrew Xiao, Qin Yan, Robert Homer, Don X. Nguyen, Katerina Politi · 年份：2024 · DOI：10.1158/0008-5472.25785278 · 研究领域：Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies、RNA modifications and cancer

<p>Expression of signature genes in residual disease in PDXs.</p>